Assessment of the risk of low bone mineral density in premenopausal Japanese female patients with systemic lupus erythematosus.
Journal of Orthopaedics(2018)
Abstract
Bisphosphonate treatment eliminated the negative relationships between disease duration and the BMD of the spine and hip. AP spine and hip BMD in patients with SLE depend on BMI, regardless of bisphosphonate use. SLE serologic markers and glucocorticoid use were not negatively associated with generalized bone loss. SLE patients with low BMI have a high risk of generalized bone loss, and should be assessed and treated to prevent osteoporosis even before menopause.
MoreTranslated text
Key words
Osteoporosis,Systemic lupus erythematosus,Bone mineral density,Body mass index,Bisphosphonate
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined